Weitere Artikel dieser Ausgabe durch Wischen aufrufen
COOL AF Investigators members of the group are listed in Acknowledgements.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The aim of this study was to investigate the factors associated with low health-related quality of life (HRQoL) compared between younger and older Thai patients with non-valvular atrial fibrillation (NVAF).
This is a cross-sectional analysis of baseline data from a prospective NVAF registry from 24 hospitals located across Thailand. Patient demographic, clinical, lifestyle, and medication data were collected at baseline. EuroQOL/EQ-5D-3L was used to assess HRQoL. Health utility was calculated for the entire study population, and low HRQoL was defined as the lowest quartile. Multivariate logistic regression was used to identify factors that significantly predict low HRQoL among younger and older (≥ 65 years) patients with NVAF.
Among the 3218 participants that were enrolled, 61.0% were aged older than 65 years. Mean HRQoL was lower in older than in younger patients (0.72 ± 0.26 vs. 0.84 ± 0.20; p < 0.001). Factors associated with low HRQoL among younger NVAF patients were the treatment-related factors bleeding history (p = 0.006) and taking warfarin (p = 0.001). Among older patients, the NVAF-related complications ischemic stroke or TIA, heart failure (HF), and dementia (all p < 0.001) were all significantly associated with low HRQoL. Dementia is the factor that most adversely influences low HRQoL among older NVAF. Interestingly, symptomatic NVAF was found to be a protective factor for low HRQoL (p < 0.001).
Bleeding history and taking warfarin among younger patients, and ischemic stroke/TIA, HF, and dementia among older patients are significant predictors of low HRQoL. These factors should be taken into consideration when selecting treatment options for patients with NVAF.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S. A., et al. (2012). 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Journal of Interventional Cardiac Electrophysiology, 33(2), 171–257. CrossRefPubMed
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. (2006). Quality of life in patients with atrial fibrillation: A systematic review. The American Journal of Medicine, 119(5), 448.e441–448.e419. CrossRef
Hsu, N. W., Tsao, H. M., Chen, H. C., Lo, S. S., Chen, S. A., & Chou, P. (2016). Different impacts of atrial fibrillation and cardiac premature contractions on the health-related quality of life in elderly people: The Yilan Study. The Tohoku Journal of Experimental Medicine, 238(1), 75–83. CrossRefPubMed
Wang, K. L., Wu, C. H., Huang, C. C., Wu, T. C., Naditch-Brule, L., Steg, P. G., et al. (2014). Complexity of atrial fibrillation patients and management in Chinese ethnicity in routine daily practice: Insights from the RealiseAF Taiwanese cohort. Journal of Cardiology, 64(3), 211–217. CrossRefPubMed
Inohara, T., Kimura, T., Ueda, I., Ikemura, N., Tanimoto, K., Nishiyama, N., et al. (2017). Effect of compliance to updated AHA/acc performance and quality measures among patients with atrial fibrillation on outcome (from Japanese Multicenter Registry). The American Journal of Cardiology, 120(4), 595–600. CrossRefPubMed
Krittayaphong, R., Winijkul, A., Methavigul, K., Wongtheptien, W., Wongvipaporn, C., Wisaratapong, T., et al. (2018). Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: A multicenter study. BMC Cardiovascular Disorders, 18(1), 174. CrossRefPubMedPubMedCentral
Rabin, R., & de Charro, F. (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals Medicine, 33(5), 337–343. CrossRef
Ha, A. C., Breithardt, G., Camm, A. J., Crijns, H. J., Fitzmaurice, G. M., Kowey, P. R., et al. (2014). Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF). Circulation: Cardiovascular Quality and Outcomes, 7(6), 896–904.
Freeman, J. V., Simon, D. N., Go, A. S., Spertus, J., Fonarow, G. C., Gersh, B. J., et al. (2015). Association between atrial fibrillation symptoms, quality of life, and patient outcomes: Results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Circulation: Cardiovascular Quality and Outcomes, 8(4), 393–402.
Biteker, M., Basaran, O., Dogan, V., Altun, I., Ozpamuk Karadeniz, F., Tekkesin, A. I., et al. (2017). Real-world clinical characteristics and treatment patterns of individuals aged 80 and older with nonvalvular atrial fibrillation: Results from the ReAl-life Multicenter Survey Evaluating Stroke Study. Journal of the American Geriatrics Society, 65(8), 1684–1690. CrossRefPubMed
Steg, P. G., Alam, S., Chiang, C.-E., Gamra, H., Goethals, M., Inoue, H., et al. (2012). Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: Data from the RealiseAF cross-sectional international registry. Heart, 98(3), 195–201. CrossRefPubMed
- Factors associated with low health-related quality of life among younger and older Thai patients with non-valvular atrial fibrillation
COOL AF Investigators
- Springer International Publishing
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta